Pharming Group N.V. (AMS:PHARM)

Pharming Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	771	627	690	707	503	812
Market Cap Growth	61.86%	-9.08%	-2.41%	40.66%	-38.05%	-17.99%
Enterprise Value	773	587	658	657	487	787
Last Close Price	1.13	0.93	1.03	1.08	0.78	1.27
PE Ratio	-	-	-	55.27	35.75	26.30
Forward PE	54.86	-	163.65	27.10	16.92	15.76
PS Ratio	2.66	2.19	3.11	3.68	2.88	4.68
PB Ratio	3.78	2.94	3.49	3.69	2.96	5.41
P/TBV Ratio	8.73	4.06	5.17	5.82	5.23	10.47
P/FCF Ratio	30.03	-	-	35.85	21.10	12.57
P/OCF Ratio	29.16	-	-	33.66	15.11	11.87
EV/Sales Ratio	2.67	2.05	2.97	3.41	2.78	4.54
EV/EBITDA Ratio	31.76	188.69	-	40.97	18.22	11.66
EV/EBIT Ratio	48.46	-	-	67.70	23.07	12.62
EV/FCF Ratio	30.11	-	-	33.29	20.43	12.19
Debt / Equity Ratio	0.54	0.51	0.78	0.82	0.84	0.88
Debt / EBITDA Ratio	4.35	17.02	-	8.46	4.88	1.92
Debt / FCF Ratio	4.26	-	-	7.91	5.97	2.05
Asset Turnover	0.79	0.69	0.55	0.50	0.49	0.63
Inventory Turnover	0.59	0.63	0.51	0.50	0.87	1.26
Quick Ratio	2.04	2.96	3.28	3.90	4.69	3.09
Current Ratio	2.80	3.77	4.06	4.65	5.33	3.43
Return on Equity (ROE)	-3.70%	-5.38%	-4.98%	6.88%	8.50%	25.09%
Return on Assets (ROA)	2.85%	-0.52%	-3.06%	1.57%	3.68%	14.13%
Return on Capital (ROIC)	3.45%	-0.62%	-3.57%	1.79%	4.29%	18.30%
Return on Capital Employed (ROCE)	5.50%	-	-	2.80%	6.80%	22.30%
Earnings Yield	-0.91%	-1.82%	-1.38%	1.81%	2.80%	3.80%
FCF Yield	3.33%	-0.40%	-2.46%	2.79%	4.74%	7.95%
Buyback Yield / Dilution	-1.47%	-2.18%	7.09%	-0.85%	-2.70%	-1.37%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.